CELL BIOTECH CO ., LTD Q3 profit from main business KRW 2.0 billion on sales of KRW 14.8 billion
AI summary · Not investment advice
Cell Biotech sold KRW 14.8 billion worth in Q3 and earned KRW 2.0 billion from its main business, down 9.4% from a year earlier.
Operating profit · 3 months
KRW 2.0 billion
Key facts
- Revenue (3 months)
- KRW 14.8 billion
- Net income (3 months)
- KRW -4.3 billion
- Period
- Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
- Revenue (prior-year 3 months)
- KRW 15.4 billion
- Revenue (year to date)
- KRW 45.3 billion
- Operating profit (prior-year 3 months)
- KRW 2.2 billion
- Operating profit (year to date)
- KRW 6.8 billion
- Net income (prior-year 3 months)
- KRW 3.4 billion
- Net income (year to date)
- KRW 4.7 billion
Commentary
AI commentary · Not investment advice
What happened
Cellbiotech reported its consolidated results for the third quarter of 2026 in a quarterly report. Sales for the latest 3 months were KRW 14.85 billion. That is 3.3% lower than the same 3 months a year earlier (KRW 15.36 billion).
In the company's terms
Operating profit (money earned from the core business) was KRW 2.01 billion for the 3 months. That is 9.4% lower than a year earlier (KRW 2.22 billion). Net income (the final profit after taxes and other costs) was a loss of KRW 4.27 billion for the 3 months. A year earlier it was a profit of KRW 3.45 billion, so it turned into a loss.
What changes for shareholders
For the cumulative period from January 1 to September 30, sales were KRW 45.26 billion. Operating profit was KRW 6.83 billion. Net income was KRW 4.69 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
C